Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/2003
10/23/2003CA2481282A1 Protein a compositions and methods of use
10/23/2003CA2481207A1 Methods of treatment using ctla-4 antibodies
10/23/2003CA2481178A1 Phosphodiesterase iv inhibitor containing pyridylacrylamide derivative
10/23/2003CA2480832A1 Nitric oxide donors, compositions and methods of use
10/23/2003CA2480763A1 Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease
10/23/2003CA2480758A1 Tyrosine kinase inhibitors
10/23/2003CA2480754A1 Tyrosine kinase inhibitors
10/23/2003CA2480415A1 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses
10/23/2003CA2480410A1 Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses
10/23/2003CA2480217A1 G-type peptides to ameliorate atherosclerosis
10/23/2003CA2478392A1 Therapeutic methods and compositions involving isoflav-3-ene and isoflavan structures
10/23/2003CA2477692A1 Cyanamides useful as reversible inhibitors of cysteine proteases
10/22/2003EP1355158A1 Method for diagnosing inflammatory and infectious diseases by detecting the phosphoprotein LASP-1 as inflammation marker
10/22/2003EP1354953A1 Smac-peptides as therapeutics against cancer and autoimmune diseases
10/22/2003EP1354950A1 Nf-kb activating gene
10/22/2003EP1354896A1 Novel monoclonal antibody
10/22/2003EP1354891A1 Medicament comprising NK4 gene or recombinant NK4 protein
10/22/2003EP1354884A1 Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as the active ingredient
10/22/2003EP1354878A2 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors
10/22/2003EP1354877A1 Hetero-tricyclic compounds having substituted amino groups
10/22/2003EP1354603A1 Concomitant drugs
10/22/2003EP1354598A2 Therapeutic uses of BR43X2 soluble receptors
10/22/2003EP1354595A1 Composition containing extracts of butyrospermum parkii and its use as medicament or dietary supplement
10/22/2003EP1354590A1 Drugs against articular failure
10/22/2003EP1354588A1 Method for delivering benzindene prostaglandind by inhalation
10/22/2003EP1354584A1 Preventives for arthritis
10/22/2003EP1354582A2 Emulsion preconcentrates containing cyclosporin or a macrolide
10/22/2003EP1354047A2 Methods for screening compounds that modulate lipid metabolism
10/22/2003EP1354042A2 Proteins and nucleic acids encoding same
10/22/2003EP1353955A2 High affinity antibodies
10/22/2003EP1353946A2 Mechanism of conditional regulation of the hypoxia-inducible factor-1 by the von hippel-lindau tumor suppressor protein
10/22/2003EP1353934A1 New inhibitors against galectins
10/22/2003EP1353927A2 Sulfamidothienopyrimidines and the use of the same as phosphodiesterase v inhibitors
10/22/2003EP1353916A2 Pyrazole compounds useful as protein kinase inhibitors
10/22/2003EP1353912A1 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
10/22/2003EP1353909A2 8-substituted-2,6-methano-3-benzazocines and 3-substituted morphinanes as opioidreceptor binding agents
10/22/2003EP1353907A2 Phosphodiesterase 4 inhibitors
10/22/2003EP1353905A2 Piperidine/piperazine-type inhibitors of p38 kinase
10/22/2003EP1353691A2 Molecular antigen array presenting amyloid beta
10/22/2003EP1353672A2 Synthesis of 3-amino-thalidomide and its enantiomers
10/22/2003EP1353659A1 Use of neurotoxic substances in producing a medicament for treating joint pains
10/22/2003EP1196135B1 Compositions comprising organosiloxane resins for delivering oral care substances
10/22/2003EP1194441B1 A2a receptor agonists
10/22/2003EP1150661B1 Topical sprays comprising a film forming composition
10/22/2003EP1047665B1 Matrix metalloprotease inhibitors
10/22/2003EP0862424B1 Pharmaceutical compositions comprising flurbiprofen
10/22/2003EP0764167B1 Bicycling lactam inhibitor of interleukin-1-beta converting enzyme
10/22/2003EP0651654B1 Use of lysozyme dimer for the manufacture of a medicament for modulating natural defensive mechanisms
10/22/2003CN1451045A IFN-alpha homologues
10/22/2003CN1451043A Dual specificity antibodies and methods of making and using
10/22/2003CN1451009A Glucocortiocoid-selective antinflammatory agents
10/22/2003CN1451005A 7-oxo pyridopyrimidines as inhibitors of a cellular proliferation
10/22/2003CN1451004A 7-oxo pyridopyrimidines
10/22/2003CN1450999A Novel piperazine derivatives
10/22/2003CN1450998A Inhibitors of copper-containing amine oxidases
10/22/2003CN1450997A Inhibitors of copper-containing amine oxidases
10/22/2003CN1450912A CD40 antagonists for use in treating psoriasis and other inflammatory skin conditions
10/22/2003CN1450905A Method for improving the cell protection
10/22/2003CN1450904A Use of ribose to prevent cramping and soreness in muscles
10/22/2003CN1450891A Formulation based on heparin, glycosaminogl ycan or heparinoid, use of the formulation and the formulation base
10/22/2003CN1450066A Porphyrin derivate with macrosubstituent, preparation process thereof and use as small molecule antioxidant
10/22/2003CN1449834A Use of 2-hydroxypropyl beta-cyclodextrin in preparing sodium new houttuy fonate injection
10/22/2003CN1449815A Medicine for treating inflammation
10/22/2003CN1449802A Traditional Chinese medicine for treating arthralgia and preparation process thereof
10/22/2003CN1449794A Radix bupleuri soft capsule pharmaceutics and preparation process thereof
10/22/2003CN1449792A Medicine composition with synergrstic action and preparation process and use thereof
10/22/2003CN1449791A Ointment for stopping arthralgia and formula
10/22/2003CN1449778A Traditional Chinese medicine composition with function of treating dysmenorrhea and beautifying
10/22/2003CN1449772A Chinese medicine for treating appendictis
10/22/2003CN1125082C Human chemokine beta-8 chemokine beta-1 and macrophage inflammatory protein-4
10/22/2003CN1125079C Cyclopeptolides
10/22/2003CN1125070C Pyrrolo [2,3-d] pyrmidine compounds, and compositions and use thereof
10/22/2003CN1125064C 3-pyridyl enantiomers and their use as analgesics
10/22/2003CN1125062C Dihydrobenzofuran and related compounds useful useful as anti-inflammatory agents
10/22/2003CN1125054C Novel imidazolidine derivatives, their preparation their use and pharmaceutical preparations comprising them
10/22/2003CN1125044C Novel prostaglandin synthase inhibitors
10/22/2003CN1125040C Therapeutic compound-fatty acid conjugates
10/22/2003CN1124848C Use of a progesterone antagonist and of a gestagen for the treatment of endometriosis or leiomyomata uteri
10/21/2003US6635786 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use
10/21/2003US6635762 Monocyclic-7H-pyrrolo[2,3-d]pyrimidine compounds, compositions, and methods of use
10/21/2003US6635680 Controlled release pellet formulation
10/21/2003US6635676 Non-toxic antimicrobial compositions and methods of use
10/21/2003US6635673 1-Aminomethyl-3,4-dimethyl-cyclopentyl acetic acid; epilepsy; neurodegenerative, neuropathological and gastrointestinal disorders; depression, anxiety, panic, pain
10/21/2003US6635671 Compounds which affect mRNA stability and uses therefor
10/21/2003US6635669 Kinase inhibitor; benign prostatic hyperplasia
10/21/2003US6635644 Pyrimido(1,6-b)pyridazine derivatives used as p38 inhibitors a mammalian protein kinase is involved in cell proliferation, cell death and response to extracellular stimuli
10/21/2003US6635640 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors
10/21/2003US6635637 Cyclic oxyguanidine protease inhibitors
10/21/2003US6635633 Substituted pyrazoles useful for treating autoimmune diseases mediated by cathepsin S
10/21/2003US6635629 For therapy and prophylaxis of inflammation, asthma, an allergic disease, chronic obstructive pulmonary disease, atopic dermatitis, solid tumors, AIDS, ischemia, and cardiac arrhythmias
10/21/2003US6635625 Chondroitin sulfate, quercetin, chitin D-glucosamine sulfate, crown sodium hyaluronate, rutin, olive kernel extract, lecithan, beeswax and water
10/21/2003US6635451 Conversion of dihomo-gamma linolenic acid (DGLA) to arachidonic acid and in the conversion of 20:4n-3 to eicosapentaenoic acid (EPA); Delta 6 desaturase and Delta 5 desaturase
10/21/2003US6635432 Administering a composition to cells and determining if it enhances or inhibits opening; tetrapeptide with amide group at carboxy end; electrophysical analysis
10/21/2003US6635274 Solution-based transdermal drug delivery system
10/21/2003US6635252 Antibodies to superoxide dismutase-4
10/21/2003US6635251 Eotaxin-specific antibodies
10/21/2003US6635234 Preparation and use of radium-223 to target calcified tissues for pain palliation, bone cancer therapy, and bone surface conditioning
10/21/2003CA2237401C Novel intermediates and their use to prepare n,n'-bridged bisindolylmaleimides
10/21/2003CA2017166C Metalloproteinase inhibitor
10/16/2003WO2003085119A1 METHOD OF ENHANCING ACTIVITY OF ANTIBODY COMPOSITION OF BINDING TO FcϜ RECEPTOR IIIa
1 ... 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 ... 1272